Overview of the Recent Transaction On September 30, 2024, Empery Asset Management, I.P (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 4,000,000 shares of Elevation Oncology Inc (ELEV, Financial). This transaction, exceuted at a price of $0.5999 per share, represents a notable increase in the firm's stake in the biotechnology company. The trade has increased Empery Asset Management's total holdings in ELEV to a substantial 4.99% of the company, marking a strategic mo ...